EU Plans Research Budget

Under new plans to reduce the European Union’s overall spending, science funding did relatively well, but research leaders want more—and they may well get it.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, JULIEN JORGELast week, when the European Union’s 27 member states agreed to reduce the organization’s overall budget for 2014-2020, the section including research spending came out with a boost of around 37 percent, reported ScienceInsider. On the face of it, that’s a good outcome for European science, but research leaders had been lobbying for more.

Under the new budget, the main science-funding program—known as Horizon 2020—would receive €70.96 billion (US$95.4 billion). But the European Commission, the EU’s executive arm, had proposed €80 billion (US$108 billion) and research leaders have argued that such a figure is the minimum required for the success of Horizon 2020, which includes several new initiatives not funded by the EU’s current science-funding program.

“Our feeling is that €80 billion is required to deliver on the ambitious and exciting proposal that the commission presented,” Paul Boyle, the chief executive of the United Kingdom's Economic and Social Research Council and president of the national science funding organization Science Europe, told ScienceInsider. “Anything other than that is disappointing news from Science Europe's perspective.”

Outside of the budget for Horizon ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies